Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.10
-0.26-1.34%
Last update: Oct 2, 9:09 AM
$19.36
N/A
Anika Therapeutics Inc (ANIK) Stock Price, Quote, News & History
ANIKNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Anika Therapeutics (NASDAQ:ANIK) through any online brokerage.
Other companies in Anika Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Anika Therapeutics has a consensus price target of $21.25.
The stock price for Anika Therapeutics (NASDAQ: ANIK) is $19.36 last updated October 2, 2026 at 9:09 AM EDT.
There are no upcoming dividends for Anika Therapeutics.
Anika Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Anika Therapeutics.
Anika Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
